Solid dispersions in the form of electrospun core-sheath nanofibers.
BACKGROUND
The objective of this investigation was to develop a new type of solid dispersion in the form of core-sheath nanofibers using coaxial electrospinning for poorly water-soluble drugs. Different functional ingredients can be placed in various parts of core-sheath nanofibers to improve synergistically the dissolution and permeation properties of encapsulated drugs and to enable drugs to exert their actions.


METHODS
Using acyclovir as a model drug, polyvinylpyrrolidone as the hydrophilic filament-forming polymer matrix, sodium dodecyl sulfate as a transmembrane enhancer, and sucralose as a sweetener, core-sheath nanofibers were successfully prepared, with the sheath part consisting of polyvinylpyrrolidone, sodium dodecyl sulfate, and sucralose, and the core part composed of polyvinylpyrrolidone and acyclovir.


RESULTS
The core-sheath nanofibers had an average diameter of 410 ± 94 nm with a uniform structure and smooth surface. Differential scanning calorimetry and x-ray diffraction results demonstrated that acyclovir, sodium dodecyl sulfate, and sucralose were well distributed in the polyvinylpyrrolidone matrix in an amorphous state due to favoring of second-order interactions. In vitro dissolution and permeation studies showed that the core-sheath nanofiber solid dispersions could rapidly release acyclovir within one minute, with an over six-fold increased permeation rate across the sublingual mucosa compared with that of crude acyclovir particles.


CONCLUSIONS
The study reported here provides an example of the systematic design, preparation, characterization, and application of a novel type of solid dispersion consisting of multiple components and structural characteristics.
School of Materials Science and Engineering, University of Shanghai for Science and Technology, Shanghai, People's Republic of China. ydg017@gmail.com
Deng-Guang
DG
Yu
Li-Min
LM
Zhu
Christopher J
CJ
Branford-White
Jun-He
JH
Yang
Xia
X
Wang
Ying
Y
Li
Wei
W
Qian
D000042:Absorption; D000212:Acyclovir / Q000737:chemistry*; D000998:Antiviral Agents / Q000737:chemistry; D003692:Delayed-Action Preparations / Q000737:chemistry*; D004058:Diffusion; D004563:Electrochemistry / Q000379:methods*; D053769:Nanocapsules / Q000737:chemistry* / Q000648:ultrastructure*; D012399:Rotation
D000998:Antiviral Agents; D003692:Delayed-Action Preparations; D053769:Nanocapsules; D000212:Acyclovir